KLK3 and benign neoplasm: Interestingly, a better use for diagnosis of these combined miRNA-PSA models than PSA as biomarker was also obtained, resulting in a higher sensitivity and specificity to discriminate not only PCa from healthy individuals, but, more clinically relevant, to discriminate malignant from benign tumours (Table 4) for the three sEV extraction methods.